The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118525153 11852515 3 F 20160903 20151218 20160903 PER US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-085459 BRISTOL MYERS SQUIBB 0.00 F Y 0.00000 20160903 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118525153 11852515 1 PS SPRYCEL DASATINIB 1 Oral 100 MG, QD U D583028B 21986 100 MG FILM-COATED TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118525153 11852515 1 White blood cell disorder

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
118525153 11852515 Arthropathy
118525153 11852515 Fatigue
118525153 11852515 Gait disturbance
118525153 11852515 Lethargy
118525153 11852515 Osteoarthritis
118525153 11852515 Product use issue
118525153 11852515 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118525153 11852515 1 20151016 0